Immunostimulatory activity of aminoalkyl glucosaminide 4-phosphates (AGPs): induction of protective innate immune responses by RC-524 and RC-529

Abstract

Earlier we showed that the structural requirements for adjuvanticity among the aminoalkyl glucosaminide 4-phosphate (AGP) class of synthetic immunostimulants may be less strict than those for other endotoxic activities, including the induction of nitric oxide synthase in murine macrophages and cytokine production in human whole blood. The known role of nitric oxide and pro-inflammatory cytokines in the activation of host defenses against infection prompted us to examine the ability of certain AGPs to enhance non-specific resistance in mice to Listeria monocytogenes and influenza infections as well as to stimulate the production of pro-inflammatory cytokines in mouse splenocytes, human PBMCs, and human U937 histiocytic lymphoma cells. Intranasal administration of RC-524 or RC-529 to mice 2 days prior to a lethal influenza challenge provided significant protection in each case. Similarly, the intravenous administration of these AGPs induced resistance to L. monocytogenes infection as measured by survival or reduction of bacteria in the spleen. Activation of the innate immune response by AGPs appears to involve activation of Toll-like receptor 4 (TLR4) because RC-524 failed to elicit a protective effect in C3H/HeJ mice which have a defect in TLR4 signaling or induce significant cytokine levels in C3H/HeJ splenocytes. Both AGPs also stimulated pro-inflammatory cytokine release in human cell cultures in a dose-dependent manner.

References

Johnson AG Molecular adjuvants and immunomodulators: new approaches to immunization. Clin Microbiol Rev 1994; 7: 277—289.

Alexander C. , Rietschel ET Bacterial lipopolysaccharides and innate immunity . J Endotoxin Res 2001; 7: 167—202.

Johnson DA , Sowell CG , Johnson CL et al. Synthesis and (pg/ml) biological evaluation of a new class of vaccine adjuvants: Aminoalkyl glucosaminide 4-phosphates (AGPs). Bioorg Med Chem Lett 1999; 9: 2273—2278.

Baldridge JR A synthetic adjuvant, RC-529, moves into the clinic. 3rd Meeting on Novel Adjuvants Currently in/close to Human Clinical Testing WHO/TDR — Fondation Merieux , 2002.

Rietschel ET , Kirikae T. , Schade FU et al. The Chemical Structure of Bacterial Endotoxin in Relation to Bioactivity. Immunobiology 1993; 187: 169—190.

DeForge LE , Kenney JS , Jones ML et al. Biphasic production of IL-8 in lipopolysaccharide (LPS)-stimulated human whole blood. Separation of LPS- and cytokine-stimulated components using anti-tumor necrosis factor and anti-IL-1 antibodies. J Immunol 1992; 148: 2133—2141.

Johnson DA , Keegan DS , Sowell CG et al. 3-O-desacyl monophosphoryllipid A derivatives: synthesis and immunostimulant activities. J Med Chem 1999 ; 42: 4640—4649.

Johnson DA , Sowell CG Aminoalkyl glucosamine phosphate compounds and their use as adjuvants and immunoeffectors. 2002; 6,355,257 B1, US.

Keegan DS , Hagen SR , Johnson DA Efficient asymmetric synthesis of (R)-3-hydroxy- and alkanoyloxytetradecanoic acids and method for the determination of enantiomeric purity. Tetrahedron Asymmetry 1996; 7: 3559—3564.

10.

Poltorak A. , He X. , Smirnova I. et al. Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: mutations in Tlr4 gene. Science 1998; 282: 2085—2088.